CIPOLLONE, Francesco
 Distribuzione geografica
Continente #
NA - Nord America 12.779
EU - Europa 10.213
AS - Asia 8.091
SA - Sud America 1.167
AF - Africa 117
Continente sconosciuto - Info sul continente non disponibili 16
OC - Oceania 14
Totale 32.397
Nazione #
US - Stati Uniti d'America 12.527
SG - Singapore 3.504
IT - Italia 2.570
CN - Cina 2.479
IE - Irlanda 1.506
SE - Svezia 1.167
UA - Ucraina 1.122
BR - Brasile 968
DE - Germania 940
GB - Regno Unito 907
TR - Turchia 818
FR - Francia 692
FI - Finlandia 445
VN - Vietnam 405
IN - India 402
RU - Federazione Russa 279
CA - Canada 155
NL - Olanda 129
HK - Hong Kong 114
PL - Polonia 101
AR - Argentina 83
AT - Austria 79
MX - Messico 73
ES - Italia 69
BD - Bangladesh 67
JP - Giappone 51
ZA - Sudafrica 49
BE - Belgio 48
ID - Indonesia 38
KR - Corea 35
EC - Ecuador 34
LT - Lituania 31
CZ - Repubblica Ceca 28
IQ - Iraq 27
EG - Egitto 21
VE - Venezuela 21
IR - Iran 20
PY - Paraguay 17
IL - Israele 15
CL - Cile 14
CO - Colombia 14
KE - Kenya 14
TH - Thailandia 14
CH - Svizzera 13
UZ - Uzbekistan 13
PK - Pakistan 12
RO - Romania 12
AE - Emirati Arabi Uniti 11
EU - Europa 11
MY - Malesia 11
AL - Albania 10
AU - Australia 8
EE - Estonia 8
GR - Grecia 8
MA - Marocco 8
DK - Danimarca 7
SA - Arabia Saudita 7
BO - Bolivia 6
DZ - Algeria 6
PH - Filippine 6
NO - Norvegia 5
QA - Qatar 5
RS - Serbia 5
SI - Slovenia 5
TT - Trinidad e Tobago 5
TW - Taiwan 5
UY - Uruguay 5
ET - Etiopia 4
HU - Ungheria 4
JO - Giordania 4
KZ - Kazakistan 4
NZ - Nuova Zelanda 4
PE - Perù 4
SK - Slovacchia (Repubblica Slovacca) 4
TN - Tunisia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AZ - Azerbaigian 3
BG - Bulgaria 3
DO - Repubblica Dominicana 3
HR - Croazia 3
JM - Giamaica 3
KG - Kirghizistan 3
LV - Lettonia 3
OM - Oman 3
PT - Portogallo 3
SN - Senegal 3
SV - El Salvador 3
BH - Bahrain 2
BS - Bahamas 2
CI - Costa d'Avorio 2
GA - Gabon 2
GD - Grenada 2
LB - Libano 2
LK - Sri Lanka 2
MD - Moldavia 2
NI - Nicaragua 2
NP - Nepal 2
PA - Panama 2
PS - Palestinian Territory 2
XK - ???statistics.table.value.countryCode.XK??? 2
Totale 32.378
Città #
Singapore 2.562
Chandler 1.869
Dublin 1.466
Jacksonville 1.336
Dallas 920
Ashburn 893
Beijing 722
Princeton 633
Southend 575
Izmir 437
Munich 418
Los Angeles 409
The Dalles 406
Nanjing 355
New York 317
Santa Clara 316
Wilmington 276
Ann Arbor 262
Chieti 257
Pescara 236
Dearborn 221
Cambridge 205
Altamura 195
Tongling 185
Helsinki 166
Boardman 163
Ho Chi Minh City 140
Buffalo 135
Nanchang 134
São Paulo 126
Milan 116
Rome 114
Redondo Beach 108
Hong Kong 99
Woodbridge 96
Washington 83
Hanoi 81
Shenyang 79
Nuremberg 75
Warsaw 71
Brooklyn 69
Tianjin 66
Denver 63
Hebei 62
Hefei 61
Montreal 60
Turku 60
Houston 58
Jiaxing 57
Council Bluffs 54
Stockholm 53
Kunming 51
Toronto 51
Orem 50
Seattle 50
London 49
Tokyo 49
Hangzhou 48
Vienna 47
Brussels 46
Norwalk 43
Chicago 42
Poplar 42
Changsha 40
Chennai 40
Jinan 39
Atlanta 37
Dong Ket 37
Florence 37
Phoenix 37
Rio de Janeiro 37
Johannesburg 34
Falls Church 32
Grevenbroich 32
Frankfurt am Main 31
Seoul 31
Boston 30
Ningbo 30
Amsterdam 29
Moscow 28
Manchester 26
San Francisco 26
Bologna 25
Zhengzhou 25
Ankara 24
Brno 22
Mexico City 22
Augusta 21
Lappeenranta 21
Belo Horizonte 20
Orange 20
Guangzhou 18
Mumbai 18
Turin 18
Changchun 17
Lanzhou 17
Leawood 17
Querétaro 17
Auburn Hills 16
Charlotte 16
Totale 19.475
Nome #
Indici di rigidità arteriosa e rischio cardiovascolare globale: risultati da una popolazione abruzzese in prevenzione primaria 517
Utilizzo della Ceus nella diagnosi differenziale delle lesioni spleniche: una milza pseudonodulare. 429
Comparison between Dutch Lipid Clinic Network (DLCN) criteria, Simon Broome register group (SB) and US MedPed Program diagnostic performance in a pediatric cohort from LIPIGEN study population: preliminary data. 252
Rosuvastatin reduces Matrix Metalloproteinase (MMP)-9 and Plasminogen Activator Inhibitor (PAI)-1 expression via a microRNA-dependent pathway 230
MicroRNA profiling in migraine without aura: Pilot study 226
Impact of migraine on fibromyalgia symptoms 204
The diagnostic performance of the Italian Society for the Study of Atherosclerosis (SISA)-modified Dutch Lipid Clinic Network (DLCN) criteria in a pediatric cohort from LIPIGEN study population: preliminary data 183
A unique microRNA signature associated with plaque instability in humans. 172
Vitamin E supplementation normalizes LDL susceptibility to oxidation in well controlled uncomplicated type II diabetes mellitus 166
Attitudes Towards and Knowledge About Lesbian, Gay, Bisexual, and Transgender Patients Among Italian Nurses: An Observational Study 160
(Dis)-agreement among Cardiovascular Risk Calculators in clinical practice 157
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 157
A prothrombotic state 153
Suppression of RAGE as a basis of simvastatin-dependent plaque stabilization in type 2 diabetes. 151
Increased expression of transforming growth factor-beta1 as a stabilizing factor in human atherosclerotic plaques. 149
Allergens in Occupational Allergy: Prevention and Management – Focus on Asthma 147
Analytical Management of Patients Undergoing Oral Anticoagulant Therapy Could Have a Strong Impact on Clinical Outcomes: A Follow-up Study 144
Long-term Positivity to SARS-CoV-2: A Clinical Case of COVID-19 with Persistent Evidence of Infection 143
Il trattamento con Metformina riduce i livelli di alcuni indicatori di stress ossidativi in diabetici di tipo 2 142
Allergooncology: an expanding research area 142
Effect of MK-571, a selective leukotriene D4 receptor antagonist, on vascular smooth muscle cell proliferation and interleukin 1 release 141
Co-occurrence of pain syndromes 140
Blockade of the angiotensin II type 1 receptor stabilizes atherosclerotic plaques in humans by inhibiting prostaglandin E2-dependent matrix metalloproteases activity 138
OVEREXPRESSION OF TOLL LIKE RECEPTOR 4 AS A BASIS OF CYCLOOXYGENASE 2-DEPENDENT ATHEROSCLEROTIC PLAQUE INSTABILITY IN HUMANS. 137
Elevated circulating levels of monocyte chemoattractant protein-1 in patients with restenosis after coronary angioplasty. 137
Necrotizing fasciitis caused by Pseudomonas Aeruginosa 136
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study 136
Calcitonin gene-related peptide receptor as a novel target for the management of people with episodic migraine: current evidence and safety profile of erenumab 135
Plasma exosome microRNA profiling unravels a new potential modulator of adiponectin pathway in diabetes: effect of glycemic control 133
A unique microRNA signature associated with ischemic stroke in humans 132
Overexpression of microRNA-145 in atherosclerotic plaques from hypertensive patients 132
A case of coinfection with SARS-COV-2 and Cytomegalovirus in the Era of Covid-19 129
A Polymorphism in the Cyclooxygenase 2 Gene as an Inherited Protective Factor Against Myocardial Infarction and Stroke 128
Preprocedural level of soluble CD40L is predictive of enhanced inflammatory response and restenosis after coronary angioplasty. 128
[Controllo dei fattori di rischio cardiovascolare nella comune pratica clinica in un campione di pazienti in prevenzione secondaria rappresentativo della popolazione abruzzese] 127
Relationship between oxidative stress, monocyte activation and restenosis after coronary angioplasty. 126
Additional Antihypertensive effect of fluvastatin in hypertensive and hypercholesterolemic patients treated with trandolapril. 126
Impaired enzymatic reactive aldehyde-detoxifying capacity and glutathione peroxidase activity in the aged human arterial tissue 126
Antibiotic use and associated factors in a large sample of hospitalized older people 126
24-months follow-up to assess the efficacy and tolerability of evolocumab in a young patient with chronic and progressive ischemic arteriopathy 126
Association between prostaglandin E receptor subtype EP4 overexpression and unstable phenotype in atherosclerotic plaques in human. 125
Cardiovascular risk in non-alcoholic fatty liver disease: Mechanisms and therapeutic implications 125
Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus 124
MicroRNA profiling reveals new potential modulators of insulin-resistance and cardiovascular risk in type 2 diabetes 123
Ultramicronized palmitoylethanolamide reduces viscero-visceral hyperalgesia in a rat model of endometriosis plus ureteral calculosis: role of mast cells 122
Differential TBXA2 receptor transcript stability is dependent on the C924T polymorphism 122
Erratum: Insight into B5-I spinal interneurons and their role in the inhibition of itch and pain 122
ATP-binding cassette transporter A1 (ABCA1) overexpression in hypercholesterolemic plaques: a potential molecular explanation 121
Effect of Rosuvastatin on MicroRNAs expression in human atherosclerotic plaques: results from Quasar Study 121
Guidelines enforcement and clinical outcome 121
microRNA profiling in atherosclerosis, diabetes, and migraine 121
Prognostic value of morning surge of blood pressure in middle-aged treated hypertensive patients 121
Effect of Rosuvastatin on ABCA1 and ABCG1 expression in human atherosclerotic plaques: results from the QUASAR study 120
Canakinumab in a subgroup of patients with COVID-19 119
Biochemical and pharmacological characterization of the cyclooxygenase activity of human blood prostaglandin endoperoxide synthases 118
ABCA-1 expression is reduced in atherosclerotic plaques from hypertensive patients: a new potential link between hypertension and atherosclerosis 118
Effects of vitamin E supplementation on intracellular antioxidant enzyme production in adolescents with type 1 diabetes and early microangiopathy. 117
Use of Nonsteroidal Anti-Inflammatory Drugs for Symptomatic Treatment of Episodic Headache 117
High preprocedural non-HDL cholesterol is associated with enhanced oxidative stress and monocyte activation after coronary angioplasty: possible implications in restenosis. 116
The black esophagus 116
Role of microRNAs in the modulation of diabetic retinopathy. 116
Association between 5-lipoxygenase expression and plaque instability in humans. 116
Cyclooxygenase-2 inhibition: vascular inflammation and cardiovascular risk. 115
Novel determinants of plaque instability. 114
LDL-Apheresis abruzzo network: an old-new opportunity for the management of patients at high cardiovascular risk. 114
High dose rosuvastatin increases ABCA1 transporter in human atherosclerotic plaques in a cholesterol-independent fashion 113
Paraoxonase activity is significantly reduced in smokers. Effect of vitamin E supplementation 112
Effects of irbesartan on intracellular antioxidant enzyme expression and activity in adolescents and young adults with early diabetic angiopathy 112
La gestione del profilo lipidico nei pazienti in prevenzione secondaria sul territorio: lo studio ELL 112
Effect of 2-year treatment with low-dose rosuvastatin on intima-media thickness in hypercholesterolemic subjects with asymptomatic carotid artery disease 112
Overexpression of ABCA1 in human plaques exposed to hypercholesterolemia: the role of microRNA modulation 111
The (K+)ey of the problem 110
Cyclooxygenase-2 polymorphism: another piece in the cardiovascular puzzle. 110
Liraglutide improves memory in obese patients with prediabetes or early type 2 diabetes: a randomized, controlled study 109
Tricuspid valve endocarditis complicated by septic pulmonary embolism in an intravenous drug user 108
ABCA-1 Expression is reduced in atherosclerotic plaques of hypertensive patient: a new link between hypertension and atherosclerosis 108
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 108
Duration of COVID-19: Data from an Italian Cohort and Potential Role for Steroids 108
The role of nitric oxide in the development of diabetic angiopathy. 107
Overexpression of functionally coupled cyclooxygenase-2 and prostaglandin E synthase in symptomatic atherosclerotic plaques as a basis of prostaglandin E(2)-dependent plaque instability. 107
MicroRNA profiling reveals new potential modulators of insulin-resistance in type 2 Diabetes 107
Disability, and not diabetes, is a strong predictor of mortality in oldest old patients hospitalized with pneumonia 107
Subcutaneous adipose tissue elastosonography in obese patients: a preliminary report 107
Cyclooxygenase-2 expression and inhibition in atherothrombosis. 106
Relationship between reduced BCL-2 expression in circulating mononuclear cells and early nephropathy in type 1 diabetes. 106
Enhanced soluble CD40 Ligand is responsible for endothelial dysfunction and monocyte activation in patients with diabetes mellitus. Effect of improved metabolic control. 106
Thromboxane-dependent platelet activation in obese subjects with prediabetes or early type 2 diabetes: Effects of liraglutide-or lifestyle changes-induced weight loss 106
Pathological Gambling among Italian Nursing Students 106
Improvement of Inflammation and Pain after Three Months’ Exclusion Diet in Rheumatoid Arthritis Patients 106
Reduced TIA-1 expression in vulnerable atherosclerotic plaques as a basis of cyclooxygenase-2-dependent plaque instability in humans. 105
Association between enhanced soluble CD40L and prothrombotic state in hypercholesterolemia: effects of statin therapy. 105
Ensuring Longer Life Study. A new model for an integrated management of patients at high cardiovascular risk. 105
Prognostic Value of Masked Uncontrolled Hypertension Defined by Different Ambulatory Blood Pressure Criteria 105
Advanced glycation end products in adolescents and young adults with diabetic angiopathy. 103
Hypertension is a determinant of ABCA1 expression in atherosclerotic plaques from hypercholesterolemic patients 103
La stratificazione del rischio di sviluppare Diabete Mellito come strumento di diagnosi precoce: lo studio DIGA 103
Inappropriate prescription of benzodiazepines in acutely hospitalized older patients 103
A case of coinfection with SARS-Cov-2 and cytomegalovirus in the era of Covid-19. 103
Contribution of Atrial Fibrillation to In-Hospital Mortality in Patients With COVID-19 103
Increased thromboxane production by monocyte prostaglandin endoperoxide synthase-2 in patients with acute myocardial infarction (pubbl. su Suppl. Circulation) 102
Totale 13.391
Categoria #
all - tutte 142.049
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 142.049


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.145 0 0 0 0 0 358 61 65 184 221 102 154
2021/20221.741 70 46 27 300 145 59 64 112 158 66 206 488
2022/20235.223 413 721 317 520 499 994 294 394 644 80 189 158
2023/20242.904 194 90 196 100 211 860 584 129 48 109 52 331
2024/20257.033 381 1.164 938 186 228 339 439 424 773 378 848 935
2025/20267.128 1.237 600 1.615 1.933 1.571 172 0 0 0 0 0 0
Totale 33.638